[1] Grieb G, Merk M, Bernhagen J, et al. Macrophage migration inhibitory factor (MIF): a promising biomarker [J]. Drug News Perspect, 2010, 23: 257-264.
[2] Xu X, Hua Y, Nair S, et al. Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy [J]. Hypertension, 2014, 63: 490-499.
[3] Koga K, Kenessey A, Ojamaa K. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy [J]. Am J Physiol Heart Circ Physiol, 2013, 304: H282-H293.
[4] Slawson S E, Roman B B, Williams D S, et al. Cardiac MRI of the normal and hypertrophied mouse heart [J]. Magn Reson Med, 1998, 39: 980-987.
[5] Kleemann R, Kapurniotu A, Frank R W, et al. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase [J]. J Mol Biol,
1998, 280: 85-102.
[6] Thiele M, Bernhagen J. Link between macrophage migration inhibitory factor and cellular redox regulation [J]. Antioxid Redox Signal, 2005, 7: 1234-1238.
[7] Luedike P, Hendgen-Cotta U B, Sobierajski J, et al. Cardioprotection through Snitros(yl)ation of macrophage migration inhibitory factor [J]. Circulation, 2012, 125: 1880-1889.
[8] Su H, Li J, Menon S, et al. Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice [J]. Circ Res, 2011, 108: 40-50.
[9] Koga K, Kenessey A, Powell S R, et al. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress [J]. Antioxid Redox
Signal, 2011, 14: 1191-1202.
[10] Miller E J, Li J, Leng L, et al. Macrophage migration inhibitory factor stimulates AMPactivated protein kinase in the ischaemic heart [J]. Nature, 2008, 451: 578-582.
[11] Qi D, Hu X,Wu X, et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion [J]. J Clin Invest, 2009, 119: 3807-3816.
[12] Zhang T T, Takimoto K, Stewart A F, et al. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin Ⅱ and phenylephrine [J]. Circ Res, 2001, 88: 476-482.
[13] Maulik S K, Kumar S. Oxidative stress and cardiac hypertrophy: a review [J]. Toxicol Mech Methods, 2012, 22: 359-366.
[14] Sag C M, Santos C X, Shah A M. Redox regulation of cardiac hypertrophy [J]. J Mol Cell Cardiol, 2014, 73: 103-111. |